| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/2013 | US20130108704 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 05/02/2013 | US20130108662 Peptides useful as cell-penetrating peptides |
| 05/02/2013 | US20130108660 Anti-trypanosome therapeutic and diagnostic applications |
| 05/02/2013 | US20130108658 Mutated structural protein of a parvovirus |
| 05/02/2013 | US20130108654 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 05/02/2013 | US20130108653 Bivalent molecules for hiv entry inhibition |
| 05/02/2013 | US20130108642 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH |
| 05/02/2013 | US20130108629 Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof |
| 05/02/2013 | US20130108614 Wound healing peptides and methods of use thereof |
| 05/02/2013 | US20130108578 Apo-2 ligand variants and uses thereof |
| 05/02/2013 | US20130108575 Antibacterial and antifungal peptides |
| 05/02/2013 | CA2853731A1 Humanized il-6 and il-6 receptor |
| 05/02/2013 | CA2853707A1 Genetically modified t cell receptor mice |
| 05/02/2013 | CA2853637A1 Monoclonal antibodies and methods of use |
| 05/02/2013 | CA2853379A1 Vectors encoding rod-derived cone viability factor |
| 05/02/2013 | CA2853373A1 Antisense modulation of gccr expression |
| 05/02/2013 | CA2853364A1 Nmda receptor modulators and uses thereof |
| 05/02/2013 | CA2853338A1 Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression |
| 05/02/2013 | CA2853125A1 Isoprene synthase variants with improved solubility for production of isoprene |
| 05/02/2013 | CA2853023A1 Geminivirus replication inhibitor |
| 05/02/2013 | CA2852962A1 Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules |
| 05/02/2013 | CA2852631A1 A gene and mutations thereof associated with seizure and movement disorders |
| 05/02/2013 | CA2851336A1 Improved hcv vaccines and methods for using the same |
| 05/02/2013 | CA2850295A1 Method for preparing human factor h |
| 05/01/2013 | EP2586794A2 Manufacture, Compositions and Uses of Coagulationfactor VIIA Modulator |
| 05/01/2013 | EP2586793A1 Chimeric molecule involving oligomerized FasL extracellular domain |
| 05/01/2013 | EP2586792A1 Modulating beta-damascenone in plants |
| 05/01/2013 | EP2586791A1 Gene cluster for biosynthesis of griselimycin and methylgriselimycin |
| 05/01/2013 | EP2586790A2 Immunogens from uropathogenic Escherichia coli |
| 05/01/2013 | EP2586789A1 Method for diagnosing gram-negative infections |
| 05/01/2013 | EP2586788A1 Prevention of disulfide bond reduction during recombinant production of polypeptides |
| 05/01/2013 | EP2586460A1 Method for designing and preparing vaccines comprising directed sequence polymer composition via the directed expansion of epitopes |
| 05/01/2013 | EP2586453A1 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 05/01/2013 | EP2586305A1 Use of neuregulin for organ preservation |
| 05/01/2013 | EP2585597A1 Plants with enhanced yield-related traits and producing method thereof |
| 05/01/2013 | EP2585592A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 05/01/2013 | EP2585590A1 Novel proteases and compositions comprising them |
| 05/01/2013 | EP2585489A1 New medium, devices and methods |
| 05/01/2013 | EP2585487A2 Coincidence detection |
| 05/01/2013 | EP2585486A1 Novel octapeptide compounds and therapeutic use thereof |
| 05/01/2013 | EP2585485A1 Insulin derivatives containing additional disulfide bonds |
| 05/01/2013 | EP2585484A1 Insulin analogues containing additional disulfide bonds |
| 05/01/2013 | EP2585483A1 Human insulin containing additional disulfide bonds |
| 05/01/2013 | EP2585482A1 Glucagon analogues |
| 05/01/2013 | EP2585481A2 Glucagon analogues |
| 05/01/2013 | EP2585480A1 Anticancer fusion protein |
| 05/01/2013 | EP2585479A2 Methyltransferase nucleic acids and polypeptides |
| 05/01/2013 | EP2585478A1 Plant eukaryotic translation initiation factor 4e |
| 05/01/2013 | EP2585477A1 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| 05/01/2013 | EP2585476A2 Colon and pancreas cancer specific antigens and antibodies |
| 05/01/2013 | EP2585107A1 Homodimeric protein constructs |
| 05/01/2013 | EP2585099A2 Immunosuppression modulating compounds |
| 05/01/2013 | EP2585089A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 05/01/2013 | CN103080309A Partial region polypeptide of REIC/DKK-3 protein |
| 05/01/2013 | CN103080302A Medium composition for culturing self-activated lymphocytes and method for culturing self-activated lymphocytes using same |
| 05/01/2013 | CN103080128A Reversed phase HPLC purification of a GLP-1 analogue |
| 05/01/2013 | CN103080127A Vacuole targeting peptides and methods of use |
| 05/01/2013 | CN103080126A Aspergillus aculeatus derived polypeptides having C4-dicarboxylic acid transporter activity and polynucleotides encoding same |
| 05/01/2013 | CN103080125A Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 05/01/2013 | CN103079585A Designer osteogenic proteins |
| 05/01/2013 | CN103076453A P16 immune cell chemical reagent kit and polypeptide sequence in preparing same |
| 05/01/2013 | CN103074374A Recombinant expression vector for human beta-NGF and recombinant cell strain containing same |
| 05/01/2013 | CN103074362A Production process and application of antibacterial peptide used in animal feed |
| 05/01/2013 | CN103074350A Identification and application of specifically expressed gene GhMADS14 of cotton fiber |
| 05/01/2013 | CN103074348A Recombinant carp Nrf2 (NF-E2-related factor 2) gene, protein, preparation and detection methods and application of recombinant carp Nrf2 gene |
| 05/01/2013 | CN103074344A Preparation method and application of taenia pisiformis 18kDa antigen |
| 05/01/2013 | CN103074319A Method for separating urokinase from human urinary trypsin inhibitor |
| 05/01/2013 | CN103074305A Recombinant varicella-zoster virus |
| 05/01/2013 | CN103073638A Method for purifying ulinastatin via affinity chromatography |
| 05/01/2013 | CN103073637A Method for purifying ulinastatin by adsorption column chromatography |
| 05/01/2013 | CN103073636A Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof |
| 05/01/2013 | CN103073635A Salbutamol artificial antigen synthesis method and application thereof to colloid gold immunity test strip |
| 05/01/2013 | CN103073634A Specific antibody against herbicide anilofos |
| 05/01/2013 | CN103073633A Antibody against 5-hydroxymethyl furfural |
| 05/01/2013 | CN103073632A Potential novel cytokine LYG1 with anti-inflammatory and anti-tumor activities, and application thereof |
| 05/01/2013 | CN103073631A Hemopoietin analogue |
| 05/01/2013 | CN103073630A Process for producing citric acid caseins by using yak milk dregs as raw materials |
| 05/01/2013 | CN103073629A Protein capable of inhibiting release of virus particles, coding sequence of protein and application in inhibiting release of retrovirus from cells |
| 05/01/2013 | CN103073628A Preparation method for extracting antibacterial peptides from wood frog bodies by using ultrasonic waves |
| 05/01/2013 | CN103073627A Method for microwave-assisted reverse micelle separation and purification of kidney bean agglutinin |
| 05/01/2013 | CN103073626A Wheat calreticulin fragment TaCRT1-206, and coding sequence and application thereof |
| 05/01/2013 | CN103073625A Hydrophobic-region-deletion HIV (Human Immunodeficiency Virus) type I Tat protein mutant sequence and applications thereof |
| 05/01/2013 | CN103073620A KDR peptides and vaccines comprising the same |
| 05/01/2013 | CN103071159A Preparation method and application of adriamycin-polypeptide compound and pharmaceutical composition |
| 05/01/2013 | CN103071152A Atherosclerotic vaccine |
| 05/01/2013 | CN102321168B Method for renaturing and purifying novel thrombopoietin |
| 05/01/2013 | CN102268081B Rice lateral root control gene OsIAAII and use thereof |
| 05/01/2013 | CN102250228B Method for improving rice potassium ion efflux antiporter |
| 05/01/2013 | CN102241763B Continuously activated growth hormone receptor gene of fishes, and preparation method and application thereof |
| 05/01/2013 | CN102241752B Protein for improving plant resistance and inducing plant defense reaction, and gene and application thereof |
| 05/01/2013 | CN102206648B Application of special salt-tolerance gene Rt-st14081 of Reaumuria trigyna Maxim. in plant salt tolerance genetic engineering |
| 05/01/2013 | CN102199202B Gene of recombinant fungal immunomodulatory protein between ganodermas, protein coded thereby, and application thereof |
| 05/01/2013 | CN102199201B Recombinant fungal immunomodulatory protein gene in Ganoderma lucidum, protein coded whereby and application thereof |
| 05/01/2013 | CN102199196B Gene engineering antibacterial peptide and preparation method and application thereof |
| 05/01/2013 | CN102190718B Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 05/01/2013 | CN102190715B Protein related with arsenic resistance of plants, and coding gene and application thereof |
| 05/01/2013 | CN102138869B Peptide-based conditioner and colorant for hair, skin and nail |
| 05/01/2013 | CN101962359B Hapten, artifical antigen and antibody of enrofloxacin and preparation method as well as application thereof |
| 05/01/2013 | CN101948529B Hydrophobic chromatography separating and purifying method for efficiently purifying metal ion binding proteins |
| 05/01/2013 | CN101948516B Establishment and application of vaccinia virus vector-based reverse genetics system |